ASSEMBLY BIOSCIENCES, INC. — Director's Dealing 2023

Feb 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2023-02-16

Reporting Person: Okazaki Jason A (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-16	Common Stock	A	12500	$0.00	Acquired	107114	Direct

Footnotes

F1: Represents shares of common stock issuable under a performance-based restricted stock unit award dated August 1, 2022. On February 16, 2023, a performance-based vesting condition was achieved with respect to these shares of common stock, which remain subject to time-based vesting and will vest in two equal installments, assuming continuous service on each vesting date, as follows: August 1, 2023 and August 1, 2024.